ROS and COVID
In recent years, the pandemic of coronavirus disease 19 (COVID-19), an infectious disease caused by variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has indisputably emerged as the predominant public health issue [...]
Saved in:
Main Authors: | , , , |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_b886688578c44eefa2b4787ee9c2c1c4 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Periklis Vardakas |e author |
700 | 1 | 0 | |a Zoi Skaperda |e author |
700 | 1 | 0 | |a Fotios Tekos |e author |
700 | 1 | 0 | |a Demetrios Kouretas |e author |
245 | 0 | 0 | |a ROS and COVID |
260 | |b MDPI AG, |c 2022-02-01T00:00:00Z. | ||
500 | |a 10.3390/antiox11020339 | ||
500 | |a 2076-3921 | ||
520 | |a In recent years, the pandemic of coronavirus disease 19 (COVID-19), an infectious disease caused by variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has indisputably emerged as the predominant public health issue [...] | ||
546 | |a EN | ||
690 | |a n/a | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Antioxidants, Vol 11, Iss 2, p 339 (2022) | |
787 | 0 | |n https://www.mdpi.com/2076-3921/11/2/339 | |
787 | 0 | |n https://doaj.org/toc/2076-3921 | |
856 | 4 | 1 | |u https://doaj.org/article/b886688578c44eefa2b4787ee9c2c1c4 |z Connect to this object online. |